Featured Posts
Join WHO and the Measles & Rubella Partnership for a practical webinar on rubella-containing vaccine (RCV) introduction, featuring real strategies from the countries navigating this process right now.
What you'll learn- How 11 countries are accessing and optimizing Gavi 6.0 funding for RCV intr...
We're excited to announce a two-part webinar series dedicated to the Vaccine Vial Monitor (VVM), the simple yet transformative tool that has helped ensure vaccine potency worldwide for three decades.
Session 1: 30 Years of VVM: A RetrospectiveJoin us for a look back at three decades of the VVM, f...
Posts
POST 01061E : VVM USE
Follow-up on Posts 01028E, 01035E, 01042E, 01050E and 01053E
3 March 2007
This posting starts with a contribution from Giridhara Babu ([log in to unmask] mailto:[log in to unmask]) from India, followed by a comment from Josoa Ralaivao ([log in to unmask] mailto:[log in to unma...
POST 01061E : VVM USE
Follow-up on Posts 01028E, 01035E, 01042E, 01050E and 01053E
3 March 2007
This posting starts with a contribution from Giridhara Babu ([log in to unmask] mailto:[log in to unmask]) from India, followed by a comment from Josoa Ralaivao ([log in to unmask] mailto:[log in to unma...
There are no discussions available here currently